Jazz Pharmaceuticals (JAZZ) Q2 2024 Earnings

1MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
2.68
3.51
4.35
5.18

Details

Expected EPS
4.17927
Actual EPS
2.68
Surprise EPS
-1.5
Surprise Percent
+35.87%

Description

Jazz Pharmaceuticals (JAZZ) has reported earnings of 2.68 per share for Q2 2024.

0 Comments

Share your thoughts